Abstract The present invention deals with innovative compounds and compositions for preventing and/or treating a newly discovered detrimental mechanism, which blocks the endogenous myelin repair capacity of the adult nervous system (NS) in diseases 5 associated with the expression of HERV-W envelope protein (ENV), in particular of its MSRV subtype. 10574149_1 (GHMatters) P99313.AU.1